Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOMAB BIO-B

2.100
+0.1909.95%
Volume:10.22M
Turnover:21.18M
Market Cap:2.53B
PE:-11.11
High:2.140
Open:1.960
Low:1.940
Close:1.910
Loading ...

SinoMab BioScience Ltd. Held Annual General Meeting

Reuters
·
Yesterday

Stock Track | SinoMab BioScience Plummets 5.64% Following Executive Director's Resignation

Stock Track
·
13 Jun

BRIEF-Sinomab Bioscience Says Shanchun Wang Resigns As Executive Director

Reuters
·
12 Jun

SinoMab BioScience Ltd - Shanchun Wang Resigns as Executive Director of SinoMab BioScience

THOMSON REUTERS
·
12 Jun

SinoMab BioScience Ltd. Announces Management Changes Following Passing of Independent Director

Reuters
·
09 Jun

SinoMab BioScience's President for China Steps Down

MT Newswires Live
·
09 Jun

SinoMab BioScience Ltd. Announces Leadership Change: Mr. Shanchun Wang Steps Down as President (China)

Reuters
·
06 Jun

SinoMab BioScience Ltd - Shanchun Wang Ceases to Act as President (PRC) of Group

THOMSON REUTERS
·
06 Jun

HK Movers | Biopharmaceutical Stocks Jump With SinoMab BioScience up 18%

Tiger Newspress
·
30 May

SinoMab BioScience Ltd. Completes New Share Subscriptions Under General Mandate

Reuters
·
29 May

SinoMab BioScience to Raise HK$124 Million from Share Issue

MT Newswires Live
·
14 May

BRIEF-Sinomab Bioscience Says Co To Issue 112.8 Million Subscription Shares

Reuters
·
13 May

SinoMab BioScience Ltd. Announces New Share Issuance Under General Mandate

Reuters
·
13 May

SinoMab BioScience Ltd - to Issue 112.8 Mln Subscription Shares at HK$1.10 Each

THOMSON REUTERS
·
13 May

SinoMab's SM17 Dermatitis Drug Achieves Endpoints in Phase 1B China Clinical Trial

MT Newswires Live
·
08 Apr

Sinomab Bioscience Narrows 2024 Loss to 185.1 Million Yuan, Revenue Rises to 2.03 Million Yuan

MT Newswires Live
·
02 Apr

SinoMab BioScience FY Net Income RMB -185.1 Million

THOMSON REUTERS
·
31 Mar